Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CyberAgent (4751.T)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (¥) Price Target (¥) Rating
2022-02-2814862300.0Neutral
2022-03-0713591900.0Buy
2022-04-2813861800.0Buy
2022-07-2213871700.0Buy
2022-07-2812791800.0Buy
2022-10-2712621700.0Buy
2023-01-2612361540.0Buy
2023-04-1411481500.0Buy
2023-07-279241400.0Buy
2023-10-177801100.0Buy
2023-11-018081000.0Buy
2024-01-10905-No Rating
2024-03-1610341200.0Buy
2024-06-25998980.0Neutral
2024-10-1110441120.0Neutral
2025-01-1510341300.0Buy
2025-02-1811571500.0Buy
2025-05-2314182100.0Buy

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.